CARDIFF UNIVERSITY

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: -

Established: 1883-01-01

Employees: 6.1K

Market Cap: -

Website: https://cardiff.ac.uk/

Clinical Trials

Neurofeedback & Alcohol Dependence

Not Applicable

Completed

Conditions: Alcohol Dependence

Interventions: Device: fMRI-based neurofeedback

First Posted Date: 2015-07-01

Last Posted Date: 2019-02-01

Lead Sponsor: Cardiff University

Target Recruit Count: 52

Registration Number: NCT02486900

Locations: 🇬🇧
School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom

Optimisation of Functional MRI-based Neurofeedback for Alcohol Use Disorders

Not Applicable

Completed

Conditions: Alcohol Abuse

Interventions: Other: Neurofeedback

First Posted Date: 2015-04-02

Last Posted Date: 2015-11-11

Lead Sponsor: Cardiff University

Target Recruit Count: 15

Registration Number: NCT02406456

Locations: 🇬🇧
School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom

Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations

Phase 2

Conditions: Acute Myeloid Leukaemia
Myelodysplastic Syndrome

Interventions: Drug: Arm E CPX-351 (200 V 300)
Drug: Arm D Small molecule or Not
Drug: Arm A Mylotarg plus DA Versus CPX-351
Drug: Arm B Vosaroxin and Decitabine
Drug: Arm F DA V IDAC
Drug: Arm C DA V FLAG-Ida V DAC

First Posted Date: 2014-10-23

Last Posted Date: 2020-01-23

Lead Sponsor: Cardiff University

Target Recruit Count: 1600

Registration Number: NCT02272478

Locations: 🇩🇰
Roskilde Hospital, Roskilde, Denmark
🇬🇧
Belfast City Hospital, Belfast, United Kingdom
🇬🇧
Blackpool Victoria Hospital, Blackpool, United Kingdom

and more 84 locations

Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)

Phase 4

Completed

Conditions: Graves' Ophthalmopathy

Interventions: Drug: Eye drop solution
Drug: Bimatoprost

First Posted Date: 2014-02-11

Last Posted Date: 2016-05-06

Lead Sponsor: Cardiff University

Target Recruit Count: 31

Registration Number: NCT02059655

Locations: 🇬🇧
University Hospital of Wales, Cardiff, United Kingdom

A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis

Phase 2

Conditions: Tuberous Sclerosis

Interventions: Drug: Everolimus (RAD001)
Drug: Placebo

First Posted Date: 2013-10-07

Last Posted Date: 2018-01-30

Lead Sponsor: Cardiff University

Target Recruit Count: 48

Registration Number: NCT01954693

Locations: 🇬🇧
Cardiff University, Cardiff, United Kingdom

Real-time fMRI Neurofeedback for Treatment of Parkinson's Disease

Not Applicable

Completed

Conditions: Parkinson's Disease

Interventions: Other: Physical Exercise
Other: Neurofeedback and Physical Exercise

First Posted Date: 2013-06-04

Last Posted Date: 2017-06-21

Lead Sponsor: Cardiff University

Target Recruit Count: 30

Registration Number: NCT01867827

Locations: 🇬🇧
School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom

Anticoagulation Length in Cancer Associated Thrombosis

Phase 2

Terminated

Conditions: Deep Vein Thrombosis
Cancer
Pulmonary Embolus
Thrombosis
Venous Thromboembolism

Interventions: Drug: Low Molecular Weight Heparin (LMWH)

First Posted Date: 2013-03-25

Last Posted Date: 2018-10-29

Lead Sponsor: Cardiff University

Target Recruit Count: 2

Registration Number: NCT01817257

Locations: 🇬🇧
Velindre NHS Trust (Velindre Cancer Centre), Cardiff, United Kingdom
🇬🇧
Aneurin Bevan Health Board (Royal Gwent Hospital), Newport, United Kingdom
🇬🇧
South Warwickshire NHS Foundation Trust (Warwick Hospital), Warwick, United Kingdom

and more 2 locations

Assessment of Risk in Chronic Airways Disease Evaluation

Completed

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

First Posted Date: 2012-08-03

Last Posted Date: 2019-05-03

Lead Sponsor: Cardiff University

Target Recruit Count: 767

Registration Number: NCT01656421

Locations: 🇬🇧
Cardiff Metropolitan University, Cardiff, United Kingdom

Neurofeedback as a Treatment Tool for Depression

Not Applicable

Completed

Conditions: Unipolar Depression

Interventions: Other: fMRI-based neurofeedback

First Posted Date: 2012-03-05

Last Posted Date: 2016-12-15

Lead Sponsor: Cardiff University

Target Recruit Count: 43

Registration Number: NCT01544205

Locations: 🇬🇧
CUBRIC, Cardiff, Wales, United Kingdom
🇬🇧
School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom

Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes

Phase 1

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Pro insulin peptide
Drug: Saline

First Posted Date: 2012-02-22

Last Posted Date: 2015-07-28

Lead Sponsor: Cardiff University

Target Recruit Count: 27

Registration Number: NCT01536431

Locations: 🇬🇧
Royal Victoria Hospital, Newcastle, United Kingdom
🇬🇧
Countess of Chester, Chester, England, United Kingdom
🇬🇧
Bristol Royal Infirmary, Bristol, United Kingdom

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy